Pharmaceutical Technology on MSN
FDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy
With a regulatory route now in place, Regenxbio expects to meet with the FDA again in July, with a BLA resubmission to follow ...
The agency took another step toward clearing a backlog of Makary-era rejections that appeared to contradict earlier ...
Scientists studying aging may be taking an important step toward understanding how to preserve the body's cells as they grow ...
Separation is highlighted as a key bottleneck in cell and gene therapy manufacturing. Current methods impact scalability, so ...
Regenxbio Inc. RGNX on Monday said it aligned with the Food and Drug Administration (FDA) regarding the next steps needed for ...
MILAN — For more than three decades, a charity here has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as a gene therapy company ...
From data lakes to streamlined production, Kriya, Opus, and Epicrispr discuss how technology is improving their operations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results